-
中文名稱:N重組抗體, Biotin偶聯
-
貨號:CSB-RA33255D1GMY
-
規格:¥1540
-
其他:
產品詳情
-
產品描述:CSB-RA33255D1GMY N重組單克隆抗體(生物素標記)是一款通過基因工程技術制備的高特異性抗體,專為靶向N蛋白設計。該抗體經哺乳動物表達系統表達純化,結合生物素標記技術,可在ELISA檢測體系中實現高效信號放大,適用于體外樣品中N蛋白的靈敏檢測與定量分析。在驗證環節中,該抗體通過嚴格的ELISA特異性測試,展現出與靶標蛋白的高親和力結合能力,且經多批次質控驗證,確保不同實驗條件下的結果穩定性和可重復性。其應用場景涵蓋基礎科研中N蛋白表達水平的檢測,例如細胞裂解液、組織勻漿液或體外重組蛋白樣本的分析,為研究N蛋白在特定生物學過程中的功能機制提供可靠工具。產品經過無菌過濾及嚴格的內毒素控制,確保實驗體系兼容性,建議配合鏈霉親和素-HRP系統使用以優化檢測靈敏度。本產品適用于科學研究用途,不應用于其他領域。
-
Uniprot No.:
-
別名:N; Nucleoprotein; N; Nucleocapsid protein; NC; Protein N
-
反應種屬:Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV)
-
免疫原:Recombinant Human Novel Coronavirus Nucleoprotein (N) (1-419aa)
-
免疫原種屬:Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV)
-
標記方式:Biotin
-
克隆類型:Monoclonal
-
抗體亞型:Mouse scFv fusion with human IgG1 Fc
-
純化方式:Affinity-chromatography
-
克隆號:1A6
-
濃度:It differs from different batches. Please contact us to confirm it.
-
保存緩沖液:Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 -
產品提供形式:Liquid
-
應用范圍:ELISA
-
Protocols:
-
儲存條件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途:For Research Use Only. Not for use in diagnostic or therapeutic procedures.
相關產品
靶點詳情
-
功能:Packages the positive strand viral genome RNA into a helical ribonucleocapsid (RNP) and plays a fundamental role during virion assembly through its interactions with the viral genome and membrane protein M. Plays an important role in enhancing the efficiency of subgenomic viral RNA transcription as well as viral replication. May modulate transforming growth factor-beta signaling by binding host smad3.
-
亞細胞定位:Virion. Host cytoplasm.
-
蛋白家族:Betacoronavirus nucleocapsid protein family
Most popular with customers
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
-
-